NR 503 Week 7 Graded Discussion Presentation Of Epidemiological Problem.

NR 503 Week 7 Graded Discussion Presentation Of Epidemiological Problem. This is a graded discussion: 100 points possible due Apr 15 Week 7: Discussion- Presenta on of Epidemiological Problem Abstract 29 71 Search entries or author  Reply This week you will share your findings from your problem paper. You will write up an abstract summarizing your findings. Your abstract should consist of 100 to 500 words. Keep in mind that an abstract should summarize your research, including its key themes and problems and providing your major conclusions. Unread    Subscribe (https:// Eleina Sapoz (h ps:// Apr 8, 2018  Hi Class and Dr. Weaver, The title of my paper is: Evaluation of Epidemiological Problem: Chlamydia Infection in Adolescents and Young Adults. Abstract The rate of sexually transmitted infections (STDs) in the United States continues to rise. Adolescents and young adults, especially females, are more susceptible to STDs. Chlamydia infection, caused by Chlamydia trachomatis, is the most frequently reported STD in the U. S. and around the world. Highest chlamydia infection rates are reported for females in the 15-24 years-old age group. The untreated infection causes pelvic inflammatory disease, infertility, ectopic pregnancy, premature birth, low birth weight, and conjunctivitis and pneumonia in newborns. Chlamydia infection is asymptomatic and therefore requires laboratory testing for diagnosing. Screening is recommended for all women younger than 25 years with high-risk sexual behavior and all pregnant women and no screening is recommended in men. In spite of the morbidity, chlamydia screening rates are subpar. Incidences of chlamydia infection are reportable to states’ 5/9/2018 Topic: Week 7: Discussion- Presentation of Epidemiological Problem Abstract  Reply  according to the legislatures and regulations, however, the states’ reporting to the Centers for Disease Control is voluntary. Family nurse practitioners care for adolescents in primary care settings, which affords them the opportunity to improve adolescents’ sexual health and reduce the rates of STDs by assessing sexual behaviors, offering screening tests, providing treatments, and educating parents and adolescents on communication techniques and STD prevention. Keywords: chlamydia infection, adolescents, prevention, sexual health, screening. (http Amy Weaver (Instructor) Apr 9, 2018  Reply   Hi Eleina, thanks for your post. Chlamydia can be asymptomatic, but it can also present with yellow discharge, abdominal pain, bleeding during sex or between menstrual cycles. On a microscopic exam, there will be too many WBC to count. I have read that as much as $16 billion annually is spent on this disease alone. Isn't that an amazing amount? (http Eleina Sapoz (h ps:// Apr 10, 2018  Hi Dr. Weaver, According to Friedman, Kachur, Noar, and McFarlane (2016) STDs present a serious public health problem with 20 million cases each year costing the nation more than $16 billion annually. The total cost of chlamydia was $516 million (Owusu-Edusei et al., 2013). 50% of STDs occur in among young people ages 15-24 with the highest rates in HPV at 14 million cases, followed by chlamydia with almost 3 million cases annually (CDC, 2017). Randell (2018) advocates for a global screening of women between ages 15-24 against USPSTF (2014) recommendation of only screening high-risk women in the same age group. Paradoxically, women will subject themselves to sexual encounters with multiple partners but will not disclose this information to providers. Thus, many more women than actually reported carry chlamydia infection. The long-term cost savings of global screening, which included testing, treatment, and subsequent outcomes, were calculated by Randell (2018) for a hypothetical population of 100,000 as follows: $105 million for no screening, $71 million for universal screening, and $89 million for risk-based screening. I think that these numbers represent a powerful defense for the global screening. Furthermore, Ditkowsky, Rahman, Hammerschlag, Kohlhoff, and Smith-Moskowitz (2017) 5/9/2018 Topic: Week 7: Discussion- Presentation of Epidemiological Problem Abstract  Reply  concluded that a chlamydia vaccination program in the U.S. would be initially costly but in the end would avert significant morbidities thus becoming cost saving. Since STDs are results of risky-behaviors, I would call it a “behavioral” disease. Because we cannot control peoples’ behaviors, I believe that Ditkowsky et al. make a good case for the government to invest in the development of an effective vaccine. References: Centers for Disease Control and Prevention. (2017). Chlamydia. Retrieved from Ditkowsky, J., Rahman, A., Hammerschlag, M. R., Kohlhloff, S., & Smith-Moskowitz, T. A. (2017). Cost-benefit analysis of Chlamydia trachomatis vaccine program in adolescent girls in the United States. Friedman, A. L., Kachur, E. E., Noar, S. M., & McFarlane, M. (2016). Health communication and social marketing campaigns for sexually transmitted disease prevention and control: What is the evidence of their effectiveness? Sexually Transmitted Diseases, 43(1), S83-S101. doi: 10.1097/OLQ. Owusu-Edusei, K. Jr., Chesson, H. W., Gift, T. L., Tao, G., Mahajan, R., Ocfemia, M. C., & Kent, C. K. (2013). The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sexually Transmitted Diseases, 40(3), 197-201. doi: 10.1097/OLQ.0b013ec6d2 Randell, M. D. (2018). The case of universal chlamydia screening. Retrieved from UPSTF. (2014). Final recommendation statement: Chlamydia and gonorrhea: Screening. Retrieved from ntFinal/chlamydia-and-gonorrhea-screening.